90357-51-0: Bicalutamide Oxirane Impurity

It is an associate impurity Bicalutamide. Bicalutamide is used together with a luteinizing hormone-releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of testosterone (a male hormone).

Additional information on CAS 90357-51-0

Catalogue No.

VE006823

CAS No.

90357-51-0

Molecular Formula

C12H9F3N2O2

Molecular Weight

270.21

Parent drug

Bicalutamide

IUPAC Name

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide

Synonyms

N/A

References

“Sci-Hub, Structural Basis for Antagonism and Resistance of Bicalutamide in Prostate Cancer, 10.1073/Pnas.0500381102.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1073/pnas.0500381102.

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

90357-51-0: Bicalutamide Oxirane Impurity

90357-51-0: Bicalutamide Oxirane Impurity
Catalogue No.

VE006823

CAS No.

90357-51-0

Molecular Formula

C12H9F3N2O2

Molecular Weight

270.21

Parent drug

Bicalutamide

IUPAC Name

N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide

Synonyms

N/A

References

“Sci-Hub, Structural Basis for Antagonism and Resistance of Bicalutamide in Prostate Cancer, 10.1073/Pnas.0500381102.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1073/pnas.0500381102.

Status

In-stock

ListName

Bicalutamide Oxirane Impurity

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden